Studies of perinuclear and nuclear translocation of the Raf-1 protein in rodent fibroblasts  by Prouty, Stephen M et al.
 .Biochimica et Biophysica Acta 1402 1998 6–16
Studies of perinuclear and nuclear translocation of the Raf-1 protein in
rodent fibroblasts
Stephen M. Prouty a,1, Anjli Maroo a,2, Cora Maucher b, Harald Mischak b, Walter Kolch b,
John M. Sedivy a,)
a Department of Molecular Biology, Cell Biology, and Biochemistry, Brown Uni˝ersity, Box G-J2, Pro˝idence, RI 02912, USA
b Institut fur Klinische Molekularbiologie und Tumorgenetic, D-81377, Munchen, Germany¨ ¨
Received 14 October 1997; accepted 23 October 1997
Abstract
Raf-1, A-Raf and B-Raf comprise a small family of highly conserved serinerthreonine protein kinases, whose activities
play a fundamental role in the control of proliferation and differentiation. The best studied family member, Raf-1, is
expressed ubiquitously and constitutively, and its activity is regulated by post-translational mechanisms. Raf-1 can be
activated by many signals that include growth factors, tumor promoters, inflammatory cytokines, calcium mobilization,
DNA damaging agents, and oxygen radicals. Ras-mediated translocation of Raf-1 to the plasma membrane is a crucial step
in its activation process, and is thought to facilitate phosphorylation by membrane-bound kinases. Raf-1 has also been
reported to undergo intracellular redistribution following its activation: to the perinuclear space in murine NIH3T3 cells and
rat hepatic Ito cells, and into the nucleus in gerbil hippocampal pyramidal cells and human MO7 leukemia cells. In contrast
to the translocation to the plasma membrane, the perinuclear andror nuclear translocation of Raf-1 has not been
investigated in detail. In this paper, we report an examination of the subcellular localization of endogenous Raf-1 in a
 .fibroblastic cell line Rat-1 commonly used in transformation assays. Using the methods of cellular fractionation as well as
in situ immunofluorescence, we show that no detectable movement of Raf-1 to the perinuclear or nuclear space can be
observed. Tethering of activated Raf to the plasma membrane does not interfere with its transforming activity. q 1998
Elsevier Science B.V.
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1. Introduction
Raf-1, A-Raf and B-Raf comprise a small family
of highly conserved serinerthreonine protein kinases,
whose activities play a fundamental role in the con-
trol of proliferation and differentiation reviewed in
w x.Refs. 1–3 . Their importance in signal transduction
is underscored by that fact that deregulation of kinase
activity causes malignant transformation. The Raf
protooncogenes are converted into dominantly-acting
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 .oncogenes by mutation such as truncation of se-
quences encoding the N-terminal regulatory domains
w x4–6 .
The best studied family member, Raf-1, is ex-
w xpressed ubiquitously and constitutively 7 , and its
activity is regulated by post-translational mecha-
nisms. In quiescent cells, Raf-1 displays a very low
level of activity, and is found phosphorylated on
w xseveral serine and threonine residues 8,9 . Activation
is accomplished by additional phosphorylations: tyro-
w xsine phosphorylation 10,11 , serine phosphorylation
 w x.independent of protein kinase C PKC 12–15 , and
w xPKC-catalyzed serine phosphorylation 16–18 . Raf-1
can be activated by many signals that include growth
factors, tumor promoters, inflammatory cytokines,
calcium mobilization, DNA damaging agents, and
oxygen radicals.
Recent work in many laboratories has delineated a
signal transduction pathway from growth factor re-
ceptors to the nuclear immediate early response that
involves Ras, Raf-1, and the MAP kinase cascade
 w x.reviewed in Refs. 19,20 . Ras-mediated transloca-
tion of Raf-1 to the plasma membrane is a crucial
step in the activation process, and is thought to
facilitate phosphorylation by membrane-bound ki-
w xnases 21–23 . The Ras–Raf-MAPK pathway partici-
pates in the induction of AP-1 activity by activating
w xc-fos transcription 24,25 . Raf-1 is also an important
component of pathways that lead to the activation of
the NF-kBrRel family of transcription factors, but
wthe exact mechanism remains to be discovered 26–
x28 .
Raf-1 has also been reported to undergo intra-
cellular redistribution following its activation: to the
w xperinuclear space in murine NIH3T3 cells 29 and
w xrat hepatic Ito cells 30 , and into the nucleus in
w xgerbil hippocampal pyramidal cells 31 and human
w xMO7 leukemia cells 32 . The various documented
intracellular translocations of the Raf-1 protein pre-
sent a confusing picture. It is not clear to what extent
the perinuclearrnuclear transformation is a general
phenomenon, or whether it is required for oncogenic
transformation. In this paper we report an examina-
tion of the subcellular localization of endogenous
 .Raf-1 in a fibroblastic cell line Rat-1 commonly
used in transformation assays. Furthermore, we show
that tethering activated Raf to the plasma membrane
does not interfere with its transforming activity.
2. Materials and methods
2.1. Cell culture
All experiments employed the cell line TGR-1,
y w xwhich is a spontaneous hprt variant 33 of an
w xearly passage subclone 34 of the Rat-1 cell line.
Cell culture and induction of quiescence by serum
w xdeprivation were as described 33 . Focus assays were
performed by incubating dishes in complete medium
for 18 days. Medium was changed every 4 days.
2.2. Recombinant DNA procedures
All recombinant DNA manipulations were per-
w xformed by standard procedures 35 . Plasmid pAM11
was constructed from the wild-type non-transfor-
.  .ming rat Neu cDNA gift of D. Stern, Yale and
w xMSV6411 v-Raf proviral DNA 36 . The fusion pro-
tein contains, respectively: amino acids 1–675 of the
mature Neu protein, a single flu-tag epitope, 11 amino
acids of Gag, and amino acids 323–648 of Raf-1.
The junction between Neu and Raf was confirmed by
DNA sequencing of the final construct. Electropora-
tion with plasmid DNA were performed as described
w x33 .
2.3. Cellular fractionation
Cells from a 10-cm dish were harvested on ice
with a rubber policeman, pelleted for 15 s in a
microfuge, washed twice with 1 ml PBS, and resus-
pended in 100 ml of ice cold 10 mM Tris pH 7.5, 10
mM NaCl, 1.5 mM MgCl , 1% wrv NP40, 1 mM2
PMSF. After 5 min on ice, nuclei were pelleted for
15 s in a microfuge, and washed once by gently
resuspending in the same buffer and repelleting. To
prepare samples for electrophoresis both the super-
 .  .natant cytoplasmic and pellet nuclear fractions
were boiled with Laemli sample buffer.
2.4. Antibodies
w xThe hybridoma cell line PBB1 37 was grown in
RPMI1640 medium supplemented with 10% fetal
calf serum. The IgG fraction was precipitated from
culture supernatants with ammonium sulfate, and fur-
ther purified by affinity chromatography on protein
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 .A-conjugated agarose beads BoehringerrMannheim
w xas described 38 . For immunofluorescence studies,
the antibodies were further purified by affinity chro-
matography on anti-mouse IgG conjugated agarose
 . w xbeads Sigma as described 38 . Raf isozyme-specific
antisera were obtained by immunizing rabbits with
KLH-conjugated peptides corresponding to the last
12 amino acids of A-raf, B-raf and Raf-1, respec-
tively. The C-termini of A-raf, B-raf and Raf-1 do
not show any sequence homology, but are conserved
between mouse, rat and man. Whole serum was used
in immunoprecipitation and immunoblotting experi-
 .ments. The anti-retinoblastoma Rb antibody was
 .Rb-Ab2 Pharmingen .
2.5. Immunoprecipitation and immunoblotting
Exponentially growing TGR-1 cells were lysed in
TBST 20 mM Tris–HCl pH 7.4, 150 mM NaCl, 2
mM EDTA, 1% Triton X-100, 1 mM PMSF, 1
mgrml leupeptin, 10 mM b-glycerophosphate, 5 mM
NaF, 10 mM Na-pyrophosphate, 1 mM orthovana-
. w xdate as described 39 . Lysates of approximately
7=108 cells were incubated with a 1:500 dilution of
the A-raf-, B-raf-, or Raf-1-specific antisera in the
presence of pro tein A agarose beads
 .BoehringerrMannheim for 2 h at 48C. Immunopre-
w xcipitates were washed three times with RIPA 38 ,
boiled in Laemli sample buffer, and resolved by
SDS–polyacrylamide gel electrophoresis SDS–
.PAGE . Western blotting analysis was performed as
w xdescribed in Refs. 33,39 , as indicated in the text.
2.6. Immunofluorescence microscopy
Cells grown on glass cover slips were rinsed in
PBS and fixed for 5 min at room temperature in 2%
w xparaformaldehyde 40 . Cover slips were incubated in
PBT PBS containing 5% wrv non-fat dry milk and
.0.2% vrv Tween-20 for 30 min at 208C, followed
by PBT containing 10 mgrml of PBB1 antibody for
3 h at 378C. After extensive washing in PBT, cover
slips were incubated in PBT containing the secondary
  .antibody fluorescein FITC -conjugated rabbit anti-
.mouse IgG; Jackson ImmunoResearch for 1 h at
378C. After extensive washing in PBS, cover slips
w xwere mounted for microscopy in antifade 41 and
observed in a Nikon Diaphote inverted microscope
fitted with an epifluorescence attachment and a Nikon
Fluor 40=1.3 n.a. lens. Specimens for confocal
microscopy were prepared in the same way and were
observed at the Yale Center for Cell Imaging in a
Bio-Rad MRC600 confocal microscope outfitted with
a Krypton–Argon laser and a Zeiss 63=1.4 n.a.
lens. Images were photographed on Kodak T-MAX
3200e film.
2.7. Purification of recombinant Raf proteins
Raf-1 and B-Raf proteins were expressed as GST-
fusion proteins in the baculovirus Sf9 insect expres-
sion system. In both cases, the GST moiety was fused
in-frame to the N-terminus of the human Raf cDNAs.
The molecular weights of the GST-B-Raf and GST-
Raf-1 fusion proteins are 121 kDa and 98 kDa,
respectively. A-Raf was expressed as a GST-fusion
protein in E. coli. The GST-A-Raf fusion protein
contains CR2 and CR3 but not CR1 of human A-Raf,
and has a molecular weight of 70 kDa. GST fusion
w xproteins were purified as described 39 .
3. Results
3.1. Cell fractionation studies
All experiments employed the cell line TGR-1
w x33 , an early passage subclone of the Rat-1 cell line.
TGR-1 cells were grown in 10% serum to conflu-
ence, rendered quiescent by serum deprivation, and
either harvested directly, or stimulated with 10%
serum for 15 min prior to harvest. Cells were frac-
tionated into nuclear and cytoplasmic fractions using
gentle lysis in NP-40 detergent. Whole cell extracts
were prepared by lysis in SDS. Raf-1 protein was
detected using immunoblot analysis with the anti-Raf
w xmonoclonal antibody PBB1 37 . Raf-1 was found
exclusively in the cytoplasmic fraction in both quies-
 .cent and serum-stimulated cells Fig. 1A . No Raf
band was detected in the nuclear fractions even after
significant overexposure of the blots, and a dilution
experiment indicated that the sensitivity was suffi-
 .cient to detect 2–3% of total Raf-1 data not shown .
The characteristic mobility shift indicative of Raf-1
phosphorylation following serum addition was clearly
visible in both whole cell and fractionated extracts.
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Fig. 1. Fractionation of cells into cytoplasmic and nuclear fractions by NP-40 lysis. Cells were fractionated as indicated in Section 2.
 .Amounts of extract equivalent to equal number of cells per lane were resolved by SDS–PAGE 8% acrylamide , followed by Western
w x  .blotting analysis 33 . The cells used for preparation of samples were either quiescent Serum y , or quiescent followed by stimulation
 . with 10% serum for 15 min Serum q . Positions of molecular weight markers are indicated in the middle of the figure 200 kDa, 116
.  .  .kDa, and 80 kDa . A Immunoblotting with anti-Raf antibody PBB1. Migration positions of underphosphorylated Raf-1 Raf and
 .  .hyperphosphorylated Raf-1 Raf-P are indicated in the left margin. B Immunoblotting with anti-Rb antibody. Migration position of Rbi
is indicated in the right margin. Both anti-Raf and anti-Rb antibodies were used at 1 mgrml.
All fractionation protocols are subject to two gen-
eral artifacts: contamination of nuclear fractions with
cytoplasm, and loss of nuclear contents into cytoplas-
mic fractions due to leakage. To address the latter,
blots were reprobed with antibodies against Rb, a
known nuclear protein. The result showed that Rb
was found exclusively in the nuclear fractions Fig.
.1B . It was therefore concluded that in TGR-1 cells,
Raf-1 does not appreciably translocate to the nucleus
following stimulation with serum.
3.2. In situ immunofluorescence studies
To allow unambiguous interpretation of subcellular
localization patterns, the antibody must react with
only a single protein species. Several bands, in addi-
tion to Raf-1, were detected in immunoblots using the
PBB1 antibody. While purification of the PBB1 anti-
body from hybridoma culture supernatants using pro-
tein A affinity chromatography followed by im-
munoaffinity chromatography anti-mouse constant
.chain did not significantly reduce the background
 .data not shown , washing of immunoblots in 0.04%
SDS was successful. Washing in the presence of
0.04% SDS essentially eliminated the background,
and also weakened, but did not eliminate, the detec-
 .tion of Raf-1 Fig. 2 . Densitometric analysis of a
series of exposures showed a clear differential effect
of the SDS-containing washes on the individual bands
 .data not shown . Electrophoresis of extracts on a
native gel followed by immunoblotting in the absence
of SDS resulted in a single band after probing with
 .the PBB1 antibody data not shown . These results
indicate that the background bands are not due to
contaminating antibodies from the serum used in the
culture of the hybridoma cells, but that the PBB1
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Fig. 2. Elimination of nonspecific PBB1 interactions by washing with SDS. Total cellular extracts were resolved by SDS–PAGE,
w xfollowed by Western blotting analysis 33 . After incubation with the secondary antibody, the immunoblots were washed for 15 min at
 .room temperature in PBS containing the indicated amounts of SDS 0%, 0.02%, and 0.04% wrv . Washing in 0.05% SDS eliminated all
 .signal, including Raf-1 not shown . See Fig. 1 for further details.
antibody recognizes related epitopes in non-Raf cellu-
lar proteins. Furthermore, it appears that these epi-
topes are exposed by the denaturation inherent in
SDS–PAGE, and are of lower affinity than the Raf-1
epitope.
TGR-1 cells grown on glass cover slips were
serum starved, stimulated with serum for 0, 2, 5, 10,
15, and 30 min, and processed for immunofluo-
rescence microscopy using double-immunoaffinity
 .purified PBB1 antibody Fig. 3A–F . All samples
were washed in the presence of 0.04% SDS. Diffuse,
weak, and somewhat granular cytoplasmic immuno-
reactivity was observed at all timepoints. No translo-
cation to the nucleus, perinuclear space, or plasma
membrane was observed following serum stimula-
tion. Omission of the PBB1 antibody resulted in the
 .complete absence of observable signal Fig. 7B , as
did washing in the presence of 0.05% SDS data not
.shown . It was therefore concluded that in TGR-1
cells, Raf-1 does not appreciably translocate to the
perinuclear space following stimulation with serum.
3.3. Genetic studies
It was shown that only 3–5% of total Raf-1 be-
comes associated with Ras and translocated to the
w xplasma membrane following serum stimulation 42 .
Since this value was determined using coimmunopre-
cipitation, it represents the lower limit of association.
Nevertheless, translocation of a minor activated frac-
tion to other cellular compartments may be difficult
to detect by the fractionation and cytological analyses
presented above. Therefore, a functional test was
designed to test whether tethering the activated Raf
kinase domain to the plasma membrane would inter-
fere with its activity in oncogenic transformation.
A fusion gene encoding the extracellular and trans-
membrane domains of the Neu protooncogene and
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Fig. 3. Cellular distribution of Raf-1 in TGR-1 cells. TGR-1 cells were grown on coverslips and processed for immunofluorescence as
 .described in Section 2. The primary antibody PBB1 was double affinity-purified, and coverslips were washed in PBS–0.04% SDS prior
to mounting. Specimens were viewed in a Nikon Diaphote inverted microscope fitted with an epifluorescence attachment and a Nikon
 .Fluor 40=1.3 n.a. lens. A Quiescent cells. Subsequent panels show quiescent cells stimulated with 10% serum at 378C for various time
 .  .  .  .  .intervals: B 2 min; C 5 min; D 10 min; E 15 min; F 30 min.
 .the Raf-1 kinase domain Neu–Raf was constructed
in a mammalian expression vector. This construct
differs from the membrane-targeted Raf-CAAX pro-
w xtein 22 in that Raf-CAAX contains full-length c-
Raf-1, whereas Neu–Raf contains only the kinase
domain of c-Raf. Therefore, the Neu–Raf protein
should not require membrane translocation for activa-
tion, but, like the v-raf protein on which it was
 .modeled a Gag–Raf fusion , Neu–Raf should be
constitutively activated. Fusion of the Raf-1 kinase
domain to the ligand-binding domain of the estrogen
w xreceptor 43 resulted in a fusion protein whose activ-
ity was directly hormone regulated, providing another
example where the growth factor-independent activ-
ity of the Raf-1 kinase domain was maintained in a
fusion protein.
Electroporation of the vector into TGR-1 cells
 .resulted in the formation of transformed foci Fig. 4 .
Electroporation of a control vector containing a
frameshift mutation early in the Raf coding region
did not produce any foci. Individual foci were cloned
with cloning rings and expanded into cell lines. The
cell lines displayed a highly transformed morphology,
as well as anchorage independent growth in soft agar
 .data not shown .
Expression of the Neu–Raf fusion protein was
Fig. 4. Transformation by the Neu–Raf fusion protein shown by
focus assay. Plasmid DNA was electroporated into TGR-1 cells.
Dishes were stained with crystal violet. Neu–RafrFS is a mutant
with a frameshift mutation early in the Raf coding region. On a
molar basis, the Neu–Raf plasmid was three-fold more effective
at inducing foci than plasmids expressing cytoplasmic truncated
w x w x  .Raf-1 proteins: EC12 44 , or BXB-Raf 45 data not shown .
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examined by immunoblotting of a representative
transformed cell line. A protein species with the
expected mobility was detected using the PBB1 anti-
body in the transformed but not the control cells Fig.
.5 . The Raf kinase domain used in the Neu–Raf
fusion construct is 37 kDa; absence of signal in that
portion of the gel indicates that the free kinase do-
Fig. 5. Synthesis of Neu–Raf fusion protein in transformed cells.
Amounts of extract equivalent to equal number of cells per lane
 .were resolved by SDS–PAGE 10% acrylamide , followed by
w xWestern blotting analysis using the PBB1 antibody 33 . TGR-
 .1rNeu–Raf lane 3 is a cell line transformed with the Neu–Raf
construct. TGR-1rNeu–Raf cells were growing exponentially in
10% serum at the time of harvest. The cells used for preparation
 . of control samples TGR-1 were either quiescent Serum y;
.lane 1 , or quiescent followed by stimulation with 10% serum for
 .15 min Serum q; lane 2 . Migration positions of Neu–Raf,
 .underphosphorylated Raf-1 Raf and hyperphosphorylated Raf-1
 .Raf-P are indicated in the right margin. The calculated molecu-i
lar weight of the Raf–Neu fusion protein is 120 kDa. Positions of
molecular weight markers are indicated in the left margin 106
.kDa, 80 kDa, 50 kDa, and 32 kDa .
Fig. 6. Cellular distribution of Neu–Raf in TGR-1 cells. TGR-
1rNeu–Raf cells were grown, fractionated, and analyzed by
immunoblotting as described in Fig. 1. Amounts of extract
equivalent to equal number of cells per lane were resolved by
 .SDS–PAGE 10% acrylamide . Migration positions of Neu–Raf
and Raf-1 are indicated in the left margin. Positions of molecular
weight markers are indicated in the right margin 180 kDa, 106
.kDa, 80 kDa .
main was not being released from the fusion protein
by proteolysis. An overexposure of the blot also
failed to detect any bands in that area data not
.shown . The endogenous Raf-1 protein was clearly
detectable at the 74 kDa position, and it migrated
entirely in the hypophosphorylated position. Quantita-
tion by densitometry showed that the Neu–Raf pro-
tein was overproduced approximately three-fold rela-
 .tive to endogenous Raf-1 data not shown .
Subcellular localization of the Neu–Raf fusion
protein was examined by cellular fractionation and
 .immunoblotting Fig. 6 . This experiment was per-
formed identically to the one described in Fig. 1. The
results showed that as is the case for the endogenous
Raf-1 protein, the Neu–Raf protein was localized in
the cytoplasmic fraction. Subcellular localization of
the Neu–Raf protein was also examined by in situ
immunofluorescence. TGR-1 cells transformed with
Neu–Raf were prepared for microscopy as described
above, probed with the PBB1 antibody, and viewed
in a Zeiss confocal microscope. The fluorescence
signal had a distinct punctate appearance and was
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Fig. 7. Cellular distribution of Neu–Raf in TGR-1 cells. TGR-1rNeu–Raf cells were grown and processed for immunofluorescence as
described in Fig. 3. Specimens were viewed in a Bio-Rad MRC600 confocal microscope outfitted with a Krypton–Argon laser and a
 .  .Zeiss 63=1.4 n.a. lens. A Specimen processed in the presence of PBB1 primary antibody. B Specimen processed in the absence of
 .  .PBB1 primary antibody. C Specimen shown in B viewed using brightfield optics.
 .localized to the periphery of the cells Fig. 7 . The
signal was more intense than in untransfected TGR-1
 .cells Fig. 3 . The punctate intracellular staining was
due to the uptake and internalization of the Neu–Raf
 .protein into endosomes data not shown . Based on
the above presented properties of the Neu–Raf fusion
 .protein, namely: 1 correct molecular weight and
 .absence of free kinase domain fragments; 2 ex-
 .pected sub-cellular localization; and 3 high trans-
forming activity, it was concluded that localization to
the plasma membrane does not appreciably interfere
with the oncogenic activity of Raf-1.
3.4. Expression of Raf-family members in TGR-1
cells
To address the issue that perinuclearrnuclear re-
distribution of other Raf family members A-Raf,
.B-Raf could influence our results, the expression of
these proteins was examined in TGR-1 cells by im-
munoblotting and immunoprecipitation. The speci-
ficity of the antibodies used is shown in Fig. 8A.
Immunoblotting failed to detect B-Raf in extracts of
Cos and TGR-1 cells, while Jurkat and PC12 cells,
which have been previously demonstrated to express
B-Raf, were positive. Cos cells transfected with a
B-Raf expression plasmid gave a positive signal. To
increase the detection limit of our assay, large
amounts of TGR-1 extracts were immunoprecipitated,
the immunoprecipitates were displayed by SDS–
PAGE, and replica blots were subsequently probed
with antibodies against the individual proteins. This
experimental approach was chosen because of its
superior sensitivity relative to simple Western im-
munoblotting analysis. The presence of Raf-1 was
 .readily revealed in this experiment Fig. 8C , how-
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 .Fig. 8. Expression of Raf family members in TGR-1 cells. A Immunoreactivity of the specific antibodies. A-Raf, B-Raf, and Raf-1
 .recombinant proteins were purified, resolved by SDS–PAGE, and immunoblotted with the indicated antibodies. B Analysis of extracts
by immunoblotting. Each lane was loaded with 100 mg of total cellular extract. The cell line designations are shown on top. CosrB-Raf
 .was an extract of Cos cells transfected with a B-Raf-expressing plasmid. C Analysis of TGR-1 cellular lysates by immunoprecipitation
followed by immunoblotting. In each lane, 7=108 TGR-1 cells were lysed and immunoprecipitated with the indicated antibodies.
Following SDS–PAGE, the immunoprecipitates were blotted with PBB1 antibody. Replicate blots were blotted with Raf-1, A-Raf, and
B-Raf antibodies. The same bands were detected with the Raf-1 antibody; no bands whatsoever were detected with the A-Raf and B-Raf
 .antibodies data not shown . Purification of recombinant proteins and immunoprecipitation methods are described in the Section 2;
w ximmunoblotting was performed as described 39 . The band at ca. 50 kDa is the immunoglobulin heavy chain, which is weakly detected
by the PBB1 antibody.
ever, no A-Raf or B-Raf were detected, even after
 .extended exposures data not shown .
4. Discussion
The subcellular localization of Raf-1 protein was
examined by fractionation studies and by immuno-
fluorescence microscopy in a rat fibroblast cell line.
Both in quiescent cells and in cells stimulated with
fresh serum, Raf-1 protein was cytoplasmic: translo-
cation to the plasma membrane, perinuclear space, or
nucleus was not observed. The work presented here
differs from that previously reported in two aspects.
First, Raf-1 was observed at physiological expression
levels and not following transfection or microinjec-
tion. Second, immunofluorescence was performed us-
ing carefully established conditions where Raf-1 was
demonstrated to be the only protein recognized by the
antibody.
The absence of apparent translocation to the plasma
membrane confirms previous co-immunoprecipitation
w xexperiments 42 which showed that only a minor
fraction becomes associated with the membrane. The
immunofluorescence microscopy results presented
here are the first to examine endogenous Raf-1 in
normal cells. Taken together with the demonstrated
functional requirement for Raf-1 activation at the
w xplasma membrane 21–23 , it therefore appears that
in normal cells only a minor fraction of total Raf-1
becomes activated following growth factor stimula-
tion.
The absence of translocation to the perinuclear
andror nuclear space is in contradiction to previous
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w xreports 29–32 . Several explanations can be sug-
gested. First, translocation may only occur in some
cell types. This report would then establish the ab-
sence of translocation as a general characteristic of
fibroblasts translocation was also not observed in
.NIH3T3 cells; data not shown . Second, none of the
previous reports established conditions for immuno-
fluorescence microscopy where the primary antibody
was demonstrated to interact exclusively with Raf-1.
It is therefore possible that some previous studies
were in fact detecting the movement of proteins
unrelated to Raf-1. Third, the appearance of perinu-
clear staining can be an artifact of cell shape. For
example, in fibroblasts, where the rounded nucleus
often projects significantly above the flat cell body,
the ‘depth’ of the cytoplasm in vertical section imme-
diately surrounding the nucleus is significantly greater
than that at the cell periphery. When viewed from
above, this can sometimes give the appearance of a
perinuclear ‘halo’ see Fig. 3A; the same specimen
viewed in a confocal microscope showed no perinu-
.clear staining . Fourth, coagulative fixatives, such as
acetone, can sometimes artifactually cause perinu-
 .clear staining of Raf-1 data not shown .
One possible complication to the interpretation of
our studies, which were focused on the Raf-1 protein,
would be the expression of other Raf family members
in TGR-1 cells, whose perinuclearrnuclear redistri-
bution could influence the total spectrum of Raf-like
activity in these cells. To address this issue, we
employed a very sensitive method to detect A-Raf
and B-Raf: substantial amounts of cellular extracts
were immunoprecipitated with specific antibodies,
and the immunoprecipitates were subsequently ana-
lyzed by immunoblotting. Using these methods we
were unable to detect either A-Raf or B-Raf in
TGR-1 cells. Although it is possible that TGR-1 cells
express A-Raf or B-Raf below the detection limit of
our assays, it is apparent that Raf-1 is the major
species expressed in TGR-1 cells.
It could be argued that only the small fraction of
Raf-1 that is activated at the plasma membrane is
subsequently translocated to the perinuclearrnuclear
space. Given the fact that our cell fractionation and
immunofluorescence studies did not detect movement
of Raf-1 to the plasma membrane, they would like-
wise be expected to miss the subsequent movement
of activated Raf-1 to the perinuclearrnuclear space.
In this case it would be predicted that depletion of the
pool of Raf-1 free to m igrate to the
perinuclearrnuclear space would interfere with its
biological activity. To avoid possible problems due to
differential activation of Raf-1 in different cellular
compartments, we chose to investigate a constitu-
tively activated Raf-1 kinase domain. We found that
fusion of the Raf-1 kinase domain to the extracellular
and transmembrane domains of a cell surface recep-
tor, and the consequent plasma membrane localiza-
tion, did not interfere with cellular transformation. In
fact, the membrane-tethered Raf-1 kinase domain was
 .a potent oncogene: 1 on a molar basis, the Neu–Raf
cDNA resulted in more efficient focus formation than
 .that elicited by v-Raf; 2 in random clones picked on
the basis of their transformed phenotype, Neu–Raf
protein expression was always lower than v-Raf pro-
 .tein expression data not shown . These results there-
fore suggest that perinuclearrnuclear Raf-1 activity
is not required for cellular transformation.
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